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Diclofenac and ibuprofen are commonly used non-steroidal anti-inflammatory drugs
(NSAIDs) in the treatment of rheumatic diseases. However, these drugs are known
to cause hepatotoxicity in patients. Recent in vitro studies indicated that the
hepatotoxic effects of these NSAIDs are related to their ability to induce apoptosis
by targeting the mitochondria. This study was carried out to investigate and to
compare possible liver perturbation following diclofenac and ibuprofen
administration to rats. Male Sprague-Dawley rats (n=144) were treated with 3mg/kg,
5mg/kg and 1Omg/kg diclofenac and ibuprofen in normal saline, intraperitonealJy at
500~I/rat/day for 15 days. The control group was administered with saline in a
similar manner. Four rats from each group were euthanised every 3 consecutive
days. While 200mg/kg diclofenac and ibuprofen-treated rats (n=4) were euthanised
following a single dose 10 hours post-treatment. Upon euthanisation, the livers were
removed and cleaned with normal saline. A section across the right lobe was taken
and fixed in 10% (v/v %) formal saline and 4% (v/v) glutaraldehyde for light (H&E
staining and TUNEL assay) and transmission electron microscopy, respectively. The
remaining samples were kept under -80°C for Western blotting analysis. The three
mg/kg diclofenac administered group at day 15 showed significant presence of
microvesicles and lymphocytic infiltration. The five mg/kg diclofenac-treated rats
revealed significant presence of microvesicles, lymphocytic and neutrophilic
infiltrations at day 15. Liver sections obtained from rats administered with 10 mg/kg
diclofenac showed significant presence of microvesic1es, mild lymphocytic and
neutrophilic infiltration and inflammation. The five mg/kg and 10mg/kg ibuprofen-
injected rats showed significant presence of microvesicles and mild focal
lymphocytic and neutrophilic infiltrations. These observations were mainly seen
around central veins (CVs). In TUNEL assay, 5mg/kg and IOmg/kg diclofenac and
IOmg/kg ibuprofen administered rats, showed apoptotic cells around the CVs at day
15. Ultrastructural study revealed swollen and ruptured mitochondrial membranes in
rats treated with 5mg/kg diclofenac, 10mg/kg diclofenac and 10mg/kg ibuprofen on
day 15. Western blotting analysis showed constant expression of cytochrome c in
liver homogenate and mitochondrial fraction on day 3,6,9, 12 and 15. However no
cytochrome c expression was detected in the cytosolic fraction. In 200 mg/kg
diclofenac and ibuprofen-treated rats, cytochrome c was detected in all 3 fractions;
homogenate, mitochondrial and cytosol. The expression of cytochrome c is higher
density in the cytosol from rats administered with diclofenac when compared to the
expression in cytosol from rats treated with ibuprofen. It can be concluded that
diclofenac is probably more potent in inducing changes in mitochondrial membrane
leading to apoptosis. However, at therapeutic dosage both drugs did not induce
prominent alteration in the mitochondria and the hepatocytes in general.
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Diclofenac dan ibuprofen merupakan antara ubat non-steroidal anti-inflammatroy
(NSAIDs) yang biasa digunakan untuk rawatan penyakit tulang dan sendi. Namun
demikian, ubat-ubatan ini boleh menyebabkan kesan toksik pada hati di kalangan
pesakit yang mengambilnya. Kajian in vitro yang terbaru mengaitkan kesan toksik
tersebut dengan kebolehan ubat-ubatan ini untuk menyebabkan apoptosis terhadap
sel-sel hepar dengan memberi kesan ke atas mitokondria. Kajian ini dijalankan
dengan tujuan untuk menganalisa dan membandingkan kesan diclofenac and
ibuprofen ke at<lS hati tikus. Tikus 'Sprague Dawley' (n=148) telah diberi 3mg/kg,
5mg/kg dan lOmg/kg diclofenac dan ibuprofen dalam normal saline melalui
intraperitonium pada 500!!1 setiap hari sehingga hari ke 15. Kumpulan kawalan telah
disuntik dengan normal saline sarna seperti kumpulan yang diuji. Manakala,
200mg/kg diclofenac dan ibuprofen telah diberi secara intraperitonium pada tikus
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(n=4) dan diautopsi selepas 10 jam. Empat tilms dari setiap kumpulan (kumpulan
kawalan dan kumpulan ujian) telah diautopsi setiap 3 hari sehingga hari ke 15.
Kemudian, organ hati dikeluarkan dan dibersihkan. Bahagian lobus kanan hati telah
diletak dalam 10% (v/v) formalin dan 4% (v/v) glutaraldehyde untuk analisa di
bawah mikroskop cahaya (celupan H&E dan esei TUNEL) dan mikroskop elektron.
Sampel selebihnya telah disimpan pada suhu -80°C untuk ujikaji 'Western blotting'.
Kajian menerusi pewarnaan 'H&E' pada 3mg/kg diclofenac menunjukkan kehadiran
mikrovesikel dan serangan limfosit yang signifikan pada hari yang ke-15. Kumpulan
yang diberi 5mg/kg diclofenac pula menunjukkan mikrovesikel, serangan limfosit
and neutrofil yang signifikan pada hari yang ke-15 juga. Kumpulan yang disuntik 10
mg/kg diclofenac juga menunjukkan kehadiran mikrovesikel, serangan limfosit,
neutrofil dan inflamasi yang signifikan pada hari yang ke-15 berbanding dengan
normal saline. Kumpulan tikus yang diberi 5mg/kg dan IOmg/kg ibuprofen pula
menunjukkan kehadiran mikrovesikel, limfosit dan neutrofil yang tertumpu selepas
hari ke-15. Pemerhatian ini telah di buat terutamanya di sekitar kawasan PVs. Dalarn
esei TUNEL, 5mg/kg diclofenac, 10mg/kg diclofenac dan 10mg/kg ibuprofen telah
menunjukkan kehadiran sel apoptosis di sekitar PV sahaja. Kajian ultrastruktur ke
atas mitokondria menunjukkan kehadiran mitokondria yang membesar dan
mitokondria dengan membran yang pecah pada 5mg/kg diclofenac, IOmg/kg
diclofenac dan 10mg/kg ibuprofen pada hari ke' 15. Analisa 'Western blot'
menunjukkan kehadiran sitokrom c dalam homogenat hati dan fraksi mitochondria
pada hari ke-3, 6,9, 12 dan 15. Tetapi, tiada sitokrom c di kesan dalam fraksi sitosol
pada semua masa. Kumpulan yang diberi 20Omg/kg diclofenac dan ibuprofen,
menunjukkan kehadiran sitokrom c dalam homogenat, fraksi mitokondria dan fraksi
sitosol. Ekspresi sitokrom c dalam fraksi sitosol adalah lebih ketara dalam kumpulan
IV
yang diberi 200mglkg diclofenac berbanding ibuprofen. Kesimpulannya, diclofenac
mungkin menyebabkan perubahan yang lebih ketara terhadap mitokondria
berbanding ibuprofen dan seterusnya membawa kepada apoptosis set-sel hepar.
Namun demikian, diclofenac dan ibuprofen tidak menyebabkan perubahan yang
mendadak terhadap mitokondria dan sel-sel hepar apabila diuji di bawah dos
terapeutik.
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homogenate on day 15 in saline (S), 3 mglkg ibuprofen (13), 5
mglkg ibuprofen (15), 10 mglkg ibuprofen (11 0), 3 mglkg
diclofenac (03), 5 mglkg diclofenac (05), 10 mglkg diclofenac
(010). Std: standard marker.
4.4.6 Figure 4.4.6: Figure indicates the expression of cytochrome c in 88
mitochondrial fraction on day 3 in saline (S), 3 mglkg ibuprofen
(13), 5 mglkg ibuprofen (15), 10 mglkg ibuprofen (11 0), 3 mglkg
diclofenac (03), 5 mglkg diclofenac (05), 10 mglkg diclofenac
(0 I 0). Std: standard marker.
4.4.7 Figure indicates the expression of cytochrome c in mitochondrial 89
fraction on day 6 in saline (S), 3 mglkg ibuprofen (13), 5 mglkg
ibuprofen (15), 10 mg/kg ibuprofen (110), 3 mglkg diclofenac
(03), 5 mglkg diclofenac (05), 10 mglkg diclofenac (010). Std:
standard marker.
4.4.8 Figure indicates the expression of cytochrome c in mitochondrial 89
fraction on day 9 in saline (S), 3 mglkg ibuprofen (13), 5 mglkg
ibuprofen (15), 10 mglkg ibuprofen (11 0), 3 mglkg diclofenac
(03), 5 mg/kg diclofenac (05), 10 mglkg diclofenac (0 I0). Std:
standard marker.
4.4.9 Figure indicates the expression of cytochrome c in mitochondrial 90
fraction on day 12 in saline (S), 3 mglkg ibuprofen (13), 5 mglkg
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ibuprofen (15), 10 mglkg ibuprofen (110), 3 mg/kg diclofenac
(D3), 5 mg/kg diclofenac (D5), 10 mg/kg diclofenac (010). Std:
standard marker.
diclofenac
4.4.10 Figure indicates the expression of cytochrome c in mitochondrial 90
fraction on day 15 in saline (S), 3 mg/kg ibuprofen (13), 5 mg/kg
ibuprofen (15), 10 mg/kg ibuprofen (110), 3 mg/kg diclofenac
(D3), 5 mg/kg diclofenac (D5), 10 mg/kg diclofenac (010). Std:
standard marker.
4.4.11 Figure indicates absence of cytochrome c expression in liver 91
cytosolic fraction on day 3 in saline (S), 3 mglkg ibuprofen (13), 5
mg/kg ibuprofen (15), 10 mg/kg ibuprofen (11 0), 3 mglkg
diclofenac (03), 5 mglkg diclofenac (05), 10 mg/kg diclofenac
(DIO). Std: standard marker.
4.4.12 Figure indicates absence of cytochrome c expression in liver 91
cytosolic fraction on day 6 in saline (S), 3 mg/kg ibuprofen (13), 5
mg/kg ibuprofen (15), 10 mg/kg ibuprofen (11 0), 3 mglkg
diclofenac (03), 5 mglkg diclofenac (05), 10 mg/kg diclofenac
(DI0). Std: standard marker.
4.4.13 Figure indicates absence of cytochrome c expression in liver 92
cytosolic fraction on day 9 in saline (S), 3 mg/kg ibuprofen (13), 5
mg/kg ibuprofen (15), 10 mg/kg ibuprofen (11 0), 3 mg/kg
diclofenac (03), 5 mg/kg diclofenac (05), 10 mg/kg diclofenac
(D10). Std: standard marker.
4.4.14 Figure indicates absence of cytochrome c expression in liver 92
cytosolic fraction on day 12 in saline (S), 3 mglkg ibuprofen (13),
5 mg/kg ibuprofen (15), 10 mg/kg ibuprofen (11 0), 3 mglkg
diclofenac (03), 5 mg/kg diclofenac (05), 10 mg/kg diclofenac
(D10). Std: standard marker.
4.4.15 Figure indicates absence of cytochrome c expression in liver 93
cytosolic fraction on day 15 in saline (S), 3 mg/kg ibuprofen (13),
5 mg/kg ibuprofen (15), 10 mg/kg ibuprofen (11 0), 3 mg/kg
diclofenac (D3), 5 mg/kg diclofenac (05), 10 mg/kg diclofenac
(D10). Std: standard marker.
4.4.16 Figure indicates presence of cytochrome c in liver homogenate 93
(HI), cytosolic fraction (CyI) and mitochondrial fraction (MtI) in a
single dose of 200 mglkg ibuprofen-treated rats and in liver
homogenate (HO),cytosolic fraction (CyD) and mitochondrial
fraction (MtD) in a single dose of 200 mg/kg diclofenac-treated
groups 10 hours post-treatment. Std: standard marker.
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CHAPTER 1
INTRODUCTION
1.1 GENERAL INTRODUCTION
Drug-induced liver injury is conceived as a major health problem affecting patients
and therefore a major concern to health care professionals and pharmaceutical
industry (Holt and Ju, 2006) and it is the most common cause for withdrawal of
drugs from the market (Brind, 2006). The pivotal role of liver in drug metabolism
often predisposes the liver to injury due to accumulation of drugs or formation of
toxic metabolites. The most common cause of hepatotoxicity in United States has
been attributed to drug-induced liver injury (Lee, 2003) of which non-steroidal anti-
inflammatory drugs (NSAIDs) are the major class (Talley et ai, 1995; Laine, 2001;
Galati et ai, 2002).
NSAIDs are a group of widely used drugs for the treatment of rheumatoid diseases
and relief pain and inflammation (Galati et ai, 2002). Occurrence of NSAIDs-
induced hepatotoxicity is identified to result in 2.2 hospitalisation per 100 000
population per year (Fry and Seeff, 1995). Hepatic injury due to NSAIDs became a
central focus following introduction of benoxaprofen in 1982, which killed almost
seventy patients worldwide (Jurima-Romet et ai, 1994). This causes withdrawal of
the drug from the market within few months of its introduction (Lewis, 1984).
Besides benoxaprofen, NSAIDs such as pirprofen, sudoxicam and bromfenac were
also withdrawn from the market due to unacceptable level ofhepatic injury (Tolman,
1998). Following review by the United States Food and Drug Administration (FDA)
